logo conference-reports

Hasil Konferensi

Educational funding by logo MSD Oncology

WCLC 2019 – A novel KRAS Inhibitor showed promising results in patients with advanced Non-Small Cell Lung Cancer

According to a phase 1 trial, AMG 510 molecule is well tolerated and shows anti-tumour activity in Non-Small Cell Lung Cancers harbouring the KRAS G12C mutation